US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Prana Biotechnology

2.06

+0.0000

Volume:- -

Turnover:- -

Market Cap:19.48M

PE:-2.61

High:2.06

Open:2.06

Low:2.06

Close:2.06

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Prana Biotechnology

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.pranabio.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Prana Biotechnology Limited develops therapies for the treatment of Alzheimer's disease, Huntington disease, and other neurodegenerative disorders in Australia. Its lead drug candidates include PBT2 for the treatment of Alzheimers and Huntingtons diseases; and PBT434 for the treatment of Parkinsonian movement disorders. The company is also developing PBT519 for the treatment of brain cancer. It also has a library of approximately 1000 metal protein attenuating compounds. Prana Biotechnology Limited was founded in 1997 and is based in Parkville, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PRAN/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PRAN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRAN\",,,,,undefined,":{"symbol":"PRAN","market":"US","secType":"STK","nameCN":"Prana Biotechnology","latestPrice":2.0597,"timestamp":1554753599999,"preClose":2.0597,"halted":8,"volume":0,"delay":0,"floatShares":8548886,"shares":9458349,"eps":-0.789921,"marketStatus":"Trading","change":0,"latestTime":"04-30 12:03:08 EDT","open":2.0597,"high":2.0597,"low":2.0597,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.789921,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746043200000},"marketStatusCode":2,"symbolChange":{"newSymbol":"ATHE","executeDate":"2019-04-09"},"adr":1,"adrRate":0,"exchange":"NASDAQ","adjPreClose":2.0597,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRAN\",,,,,undefined,":{"symbol":"PRAN","floatShares":8548886,"roa":"--","roe":"--","lyrEps":-0.68787,"shares":9458349,"dividePrice":0,"high":2.0597,"amplitude":0,"preClose":2.0597,"low":2.0597,"week52Low":1.0854,"pbRate":"2.79","week52High":2.91,"institutionHeld":0.002,"latestPrice":2.0597,"eps":-0.789921,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.789921,"open":2.0597},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.pranabio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0513},{"period":"1month","weight":-0.0024},{"period":"3month","weight":-0.0789},{"period":"6month","weight":-0.0252},{"period":"1year","weight":0.0868},{"period":"ytd","weight":-0.0542}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Prana Biotechnology Limited develops therapies for the treatment of Alzheimer's disease, Huntington disease, and other neurodegenerative disorders in Australia. Its lead drug candidates include PBT2 for the treatment of Alzheimers and Huntingtons diseases; and PBT434 for the treatment of Parkinsonian movement disorders. The company is also developing PBT519 for the treatment of brain cancer. It also has a library of approximately 1000 metal protein attenuating compounds. Prana Biotechnology Limited was founded in 1997 and is based in Parkville, Australia.","exchange":"NASDAQ","name":"Prana Biotechnology","nameEN":"Prana Biotechnology"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PRAN\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PRAN\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PRAN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PRAN\",market:\"US\",delay:false,,,undefined,":{}}}